Human Microbiota for Pharmacy

This Professional Master’s Degree provides you with the most recent information in the field of Human Microbiota for Pharmacy so that you do not lose sight of all the advances achieved"

From the epigenetic-microbiota interaction, the recovery of the intestinal flora with probiotics and prebiotics, to the most recent debate on fecal transplantation, the great relevance of the Human Microbiota for Pharmacy has been the focus of scientific studies. Likewise, the multiple possibilities it offers for prevention and intervention in patients with different pathologies makes understandable the arduous work that is being developed in reference research centers and laboratories.  

The information, however, is not only in the scientific circle, but even the population itself has found special interest in knowing the benefits of maintaining an adequate flora, as well as the use of prebiotics and probiotics. In this scenario, the pharmaceutical professional must keep abreast of recent advances in Human Microbiota for Pharmacy. This is why TECH has brought together in this Professional Master’s Degree the best professionals in this field, with the main purpose of offering students an update of their knowledge in this area.  

To this end, students will be provided a syllabus that will give them the necessary tools to learn about the most recent advances in understanding the functioning of the human organism, the clinical applications of probiotics and prebiotics in cardiovascular disorders, urology, gynecology and immunology. Likewise, the clinical cases elaborated by the specialists and to which the students will have access, will allow them to obtain a much more direct and close vision of their application in different pathologies.  

Thus, with this Professional Master’s Degree, pharmacists will be able to be up to date through an education taught exclusively online. In addition, students will be able to conveniently access the syllabus hosted on the virtual campus whenever and wherever they wish. The pharmacist only needs an electronic device with an internet connection to connect to the platform and view the content. The professionals are, therefore, faced with a quality, flexible education that is compatible with their work and/or personal responsibilities.

Multimedia content and clinical cases will give you a comprehensive and direct overview of the progress in the use of probiotics in patients 
with mental illness"  

This Professional Master’s Degree in Human Microbiota for Pharmacy contains the most complete and up-to-date scientific program on the market. Its most notable features are:

• Clinical cases presented by experts in Human Microbiota 
• Its graphic, schematic and practical contents, with which they are conceived, gather scientific and assistance information on those disciplines that are essential for professional practice
• New diagnostic-therapeutic developments on assessment, diagnosis, and intervention in problems or disorders related to the Microbiota 
• Contains practical exercises, where the process of self-assessment can be carried out to improve learning 
• An algorithm-based interactive learning system for decision-making in the clinical situations presented throughout the course 
• With special emphasis on evidence-based medicine and research methodologies in Human Microbiota 
• All of this will be complemented by theoretical lessons, questions to the expert, debate forums on controversial topics, and individual reflection assignments
• Content that is accessible from any fixed or portable device with an Internet connection

Access the latest and most current knowledge on the clinical application of probiotics in patients with cardiovascular disorders" 

The program includes, in its teaching staff, professionals belonging to the field of medicine and pharmacy, who bring to this training the experience of their work, as well as recognized specialists from leading societies and prestigious universities. 

The multimedia content, developed with the latest educational technology, will provide the professional with situated and contextual learning, i.e., a simulated environment that will provide immersive training programmed to learn in real situations. 

This program is designed around Problem-Based Learning, whereby the professional must try to solve the different professional practice situations that arise during the academic year. For this purpose, the Professional will be assisted by an innovative Interactive Video System, developed by Renowned and Experienced Experts in Pharmacy   

You have at your disposal the best teaching team in microbiota. They will provide you with the latest information on advances in pediatric intestinal microbiota"

You have an advanced syllabus that you can access 24 hours a day from your computer. A simple method to keep up to date in Human Microbiota for Pharmacy"

The professional who takes this Professional Master's Degree will obtain the most recent information in the field of human microbiota, thanks to a syllabus that has been prepared by specialists who are currently working in this field. In addition, the progression through this program will be much smoother, thanks to the Realearning system, used by TECH in all its degrees. With it, students also reduce the long hours of study that are so frequent in other teaching methods.

The Relearning system applied by TECH will help you reduce the long hours of study so common in other methodologies"

Module 1. Microbiota. Microbiome. Metagenomics

1.1. Definition and Relationship Between Them 
1.2. Composition of the Microbiota: Types, Species and Strains 
1.3. Different Human Microbiota. General Overview of Eubiosis and Dysbiosis 

1.3.1. Gastrointestinal Microbiota 
1.3.2. Oral Microbiota 
1.3.3. Skin Microbiota 
1.3.4. Respiratory Tract Microbiota 
1.3.5. Urinary Tract Microbiota 
1.3.6. Reproductive System Microbiota 

1.4. Factors that Influence Microbiota Balance and Imbalance 

1.4.1. Diet and Lifestyle. Gut-Brain Axis 
1.4.2. Antibiotic Therapy 
1.4.3. Epigenetic-Microbiota Interaction. Endocrine Disruptors 
1.4.4. Probiotics, Prebiotics, Symbiotics. Concepts and Overviews 
1.4.5. Fecal Transplant, Latest Advances 

Module 2. Gut Microbiota I. Intestinal homeostasis 

2.1. Gut Microbiota Studies 

2.1.1. Projects MetaHIT, Meta-Biomed, MyNewGut, Human Microbiome Project 

2.2. Microbiota Composition 

2.2.1. Protective Microbiota (Lactobacillus, Bifidobacterium, Bacteroides) 
2.2.2. Immunomodulatory Microbiota (Enterococcus faecalis and Escherichia coli) 
2.2.3. Mucoprotective or Muconutritive Microbiota (Faecalibacterium prausnitzii and Akkermansia muciniphila) 
2.2.4. Microbiota with Proteolytic or Proinflammatory Activities (E. coli Biovare, Clostridium, Proteus, Pseudomonas, Enterobacter, Citrobacter, Klebsiella, Desulfovibrio, Bilophila) 
2.2.5. Fungal Microbiota (Candida, Geotrichum) 

2.3. Digestive System Physiology. Composition of the Microbiota in the Different Parts of the Digestive Tract. Resident Flora and Transient or Colonizing Flora. Sterile Areas in the Digestive Tract 

2.3.1. Esophageal Microbiota 

2.3.1.1. Healthy Individuals 
2.3.1.2. Patients (Gastric Reflux, Barrett's Esophagus, etc.) 

2.3.2. Gastric Microbiota 

2.3.2.1. Healthy Individuals 
2.3.2.2. Patients (Gastric Ulcer, Gastric Cancer, MALT, etc) 

2.3.3. Gallbladder Microbiota 

2.3.3.1. Healthy Individuals 
2.3.3.2. Patients (Cholecystitis, Cholelithiasis, etc.) 

2.3.4. Small Intestine Microbiota 

2.3.4.1. Healthy Individuals 
2.3.4.2. Patients (Inflammatory Bowel Disease, Irritable Bowel Syndrome, etc.) 

2.3.5. Colon Microbiota 

2.3.5.1. Healthy Individuals. Enterotypes 
2.3.5.2. Patients (Inflammatory Bowel Disease, Crohn's Disease, Colon Carcinoma, Appendicitis, etc.

2.4. Gut Microbiota Functions: Metabolic. Nutritional and Trophic. Protective and Barrier. Immunological 

2.4.1. Interrelationships Between the Intestinal Microbiota and Distant Organs (Brain, Lung, Heart, Liver, Pancreas, etc.) 

2.5. Intestinal Mucosa and Mucosal Immune System 

2.5.1. Anatomy, Characteristics, and Functions (MALT, GALT, and BALT System) 

2.6. What is Intestinal Homeostasis? Role of Bacteria in Intestinal Homeostasis 

2.6.1. Effects on Digestion and Nutrition 
2.6.2. Defence Stimulation, Hindering Colonization by Pathogenic Microorganisms 
2.6.3. Production of Vitamin B and K 
2.6.4. Production of Short Chain Fatty Acids (Butyric, Propionic, Acetic, etc.) 
2.6.5. Production of Gases (Methane, Carbon Dioxide, Molecular Hydrogen). Properties and Functions 
2.6.6. Lactic Acid 

Module 3. Gut Microbiota II. Intestinal Dysbiosis

3.1. What is Intestinal Dysbiosis? Consequences 
3.2. Intestinal Barrier. Physiology. Function. Intestinal Permeability and Hyperpermeability. Relationship between Intestinal Dysbiosis and Intestinal Hyperpermeability 
3.3. Relationship of Intestinal Dysbiosis and Other Types of Disorders: Immunological, Metabolic, Neurological and Gastric (Helicobacter Pylori) 
3.4. Consequences of the Alteration of the Intestinal Ecosystem and its Relationship to Functional Digestive Disorders 

3.4.1. Inflammatory Bowel Disease IBD 
3.4.2. Chronic Inflammatory Bowel Diseases: Crohn's Disease. Ulcerative Colitis 
3.4.3. Irritable Bowel Syndrome (IBS) and Diverticulitis 
3.4.4. Intestinal Motility Disorders. Diarrhea. Diarrhea Caused by Clostridium Difficile. Constipation 
3.4.5. Digestive Disorders and Nutrient Malabsorption Problems: Carbohydrates, Proteins, and Fats 
3.4.6. Markers of Intestinal Inflammation: Calprotectin. Eosinophil Cationic Protein (ECP). Lactoferrin. Lysozyme
3.4.7. Leaky Gut Syndrome. Permeability Markers: Alpha-1 Antitrypsin. Zonulin. Tight Junctions and their Main Function 

3.5. Alteration of the Intestinal Ecosystem and its Relationship with Intestinal Infections 

3.5.1. Viral Intestinal Infections 
3.5.2. Bacterial Intestinal Infections 
3.5.3. Intestinal Infections due to Parasites 
3.5.4. Fungal Intestinal Infections. Intestinal Candidiasis

3.6. Composition of the Intestinal Microbiota in the Different Stages of Life 

3.6.1. Composition of the Intestinal Microbiota in Adulthood. “Stable Period” 
3.6.2. Gut Microbiota Composition in the Elderly "Unstable Stage". Aging and Microbiota 
3.6.3. Variation in Gut Microbiota Composition from the Neonatal-Early Childhood Stage to Adolescence. “Unstable Period” 

3.7. Nutritional Modulation of Intestinal Dysbiosis and Hyperpermeability: Glutamine, Zinc, Vitamins, Probiotics, Prebiotics 
3.8. Techniques for Quantitative Analysis of Microorganisms in Feces 
3.9. Current Lines of Research 

Module 4. Microbiota in Neonatology and Pediatrics

4.1. Mother-Child Symbiosis
4.2. Influencing Factors on the Gut Microbiota of the Mother during Pregnancy and during Birth. Influence of the Type of Delivery on the Microbiota of the New-born 
4.3. Type and Duration of Breastfeeding, Influence on the Infant’s Microbiota 

4.3.1. Breast Milk: Composition of the Breast Milk Microbiota. Importance of Breastfeeding in the New-born’s Microbiota 
4.3.2. Artificial Breastfeeding. Use of Probiotics and Prebiotics in Infant Milk Formulas 

4.4. Clinical Applications of Probiotics and Prebiotics in Pediatric Patients 

4.4.1. Digestive Diseases: Functional Digestive Disorders, Diarrhea, Necrotizing Enterocolitis. Intolerances 
4.4.2. Non-digestive Pathologies: Respiratory and ENT, Atopic Diseases, Metabolic Diseases. Allergies

4.5. Influence of Antibiotic and other Psychotropic Treatment on the Microbiota of the Infant
4.6. Current Lines of Research 

Module 5. Oral Microbiota and Respiratory Tract

5.1. Structure and Oral Ecosystems 

5.1.1. Main Ecosystems that are Found in the Oral Cavity. Characteristics and Composition of Each of Them. Nostrils, Nasopharynx and Oropharynx 

5.2. Alterations of the Oral Microbial Ecosystem: Oral Dysbiosis. Relationship with Different Oral Disease States 

5.2.1. Cavities 
5.2.2. Halitosis 
5.2.3. Periodontal and Gingival Diseases 
5.2.4. Peri-Implant Diseases 
5.2.5. Other Infectious Diseases: Candida Albicans 

5.3. Influence of External Agents in Oral Eubiosis and Dysbiosis. Hygiene 
5.4. Structure of the Respiratory Tract and Composition of the Microbiota and Microbiome  

5.4.1. Upper Respiratory Tract (Nasopharynx, Middle Ear, Sinuses, and Tonsils) 
5.4.2. Lower Respiratory Tract (Trachea, Lungs, Bronchi, Bronchioles, and Alveoli) 

5.5. Factors that Regulate the Respiratory Microbiota 

5.5.1. Microbial Immigration 
5.5.2. Elimination of Microbes and the Reproduction Rates of its Members 

5.6. Alteration of the Respiratory Tract Microbiota and its Relationship with Different Respiratory Tract Diseases 
5.7. Therapeutic Manipulation of the Microbiome of the Oral Cavity in Prevention and Treatment of Diseases Related to it 
5.8. Therapeutic Manipulation of the Microbiome of the Respiratory Tract in Prevention and Treatment of Related Diseases 
5.9. Current Lines of Research and Clinical Applications 

Module 6. Microbiota and Immune System

6.1. Immune System Physiology: What is Immunity? 

6.1.1. Immune System Components 

6.1.1.1. Lymphoid Tissue 
6.1.1.2. Immune Cells 
6.1.1.3. Chemical Systems 

6.2. Organs Involved in Immunity 

6.2.1. Primary Organs
6.2.2. Secondary Organs

6.3. Innate, Non-Specific, or Natural Immunity 
6.4. Acquired, Adaptive, or Specific Immunity 
6.5. Nutrition and Lifestyle and their Interaction with the Immune System and the Microbiota 
6.6. Functional Foods and their Effect on the Immune System 

6.6.1. Probiotics, Prebiotics, and Symbiotics 
6.6.2. Nutraceuticals and Functional Foods 

6.7. Bidirectional Relationship Between Microbiota and the Neuroimmunoendocrine System 
6.8. Microbiota, Immunity, and Nervous System Disorders: Anxiety, Depression, Autism, Schizophrenia, or Alzheimer’s Disease 
6.9. The Gut-Microbiota-Brain Axis 
6.10. Current Lines of Research 
6.11. Microbiota, Immunity, and Nervous System Disorders: Anxiety, Depression, Autism, Schizophrenia, or Alzheimer’s Disease 
6.12. The Gut-Microbiota-Brain Axis 
6.13. Current Lines of Research 

Module 7. Skin Microbiota

7.1. Skin Physiology 

7.1.1. Structure of the Skin: Epidermis, Dermis, and Hypodermis 
7.1.2. Functions of the Skin 
7.1.3. Microbial Composition of the Skin 

7.2. Factors that Regulate the Type of Bacterial Flora in the Skin 

7.2.1. Sweat Glands, Sebaceous Glands, Desquamation 
7.2.2. Factors that Alter the Ecology of the Skin and its Microbiota

7.3. Skin Immune System 

7.3.1. Epidermis; Essential Element of our Defences 
7.3.2. Elements of the Cutaneous Immune System: Cytosines, Keratinocytes, Dendritic Cells, Lymphocytes, Antimicrobial Peptides 
7.3.3. Influence of the Skin Microbiota on the Skin Immune System. Staphylococcus Epidermidis, Staphylococcus Aureus 

7.4. Alteration of the Normal Skin Microbiota (Dysbiosis) 

7.4.1. Impaired Barrier Function 

7.5. Triggered Skin Diseases 

7.5.1. Psoriasis (Streptococcus Pyogenes) 
7.5.2. Acne Vulgaris
7.5.3. Atopic Dermatitis
7.5.4. Rosacea

7.6. Influence of the use of Probiotics in the Prevention and Treatment of Different Skin Diseases 
7.7. Current Lines of Research 

Module 8. Genitourinary Tract Microbiota

8.1. Genitourinary Tract Physiology and Microbial Composition 

8.1.1. In Men 
8.1.2. In Women 

8.2. Microorganisms Causing Urinary Tract Infections: Uropathogens. Relationship with the Alteration of the Microbiota in Men and Women 

8.2.1. Enteric Bacteria, Generally Gram-Negative Aerobic Bacteria: E. Coli, Enterobacteria. Klebsiella or Proteus Mirabilis or Pseudomonas Aeruginosa 
8.2.2 Gram-Positive Bacteria: Staphylococcus Saprophyticus, etc. 

8.3. Vaginal Microbiota and its Modification with Age 

8.3.1. Infant Age
8.3.2. Fertile Age 
8.3.3. Adult Age (Menopause) 

8.4. Alteration of the Vaginal Homeostasis and its Relationship with Infectious Pathologies 

8.4.1. Vaginitis

8.4.1.1.Clamidiasis 
8.4.1.2. Bacterial Vaginosis 
8.4.1.3. Vaginal Candidiasis
8.4.1.4. Vaginitis Trichomoniasis
8.4.1.5. Viral Vaginitis

8.4.2. Non-Infectious Vaginitis
8.5. Probiotics in the Prevention of the Main Genitourinary Tract Infections: UTI (Cystitis/Urethritis), Prostatitis, Pyelonephritis, Vaginal infections, and infertility 
8.6. Current Lines of Research 

Module 9. Relationship between Intolerances/Allergies and Microbiota 

9.1. Microbiota changes in Patients on Food Exclusion Diets 

9.1.1. Eosinophilic Esophagitis (EoE) 

9.2. Microbiota Changes in Patients on Food Exclusion Diets: Intolerance to Dairy 

9.2.1. Lactose Intolerance 
9.2.2. Intolerant to Lactic Proteins: Caseins, Albumins, etc. 
9.2.3. People Allergic to Milk 

9.3. Microbiota Changes in Patients on Food Exclusion Diets: Gluten

9.3.1. Alteration of the Intestinal Microbiota in Patients with Gluten Intolerance 
9.3.2. Alteration of the Intestinal Microbiota in Celiac Patients 
9.3.3. Role of Probiotics and Prebiotics in the Recovery of the Microbiota in Gluten Intolerant and Celiac Patients 

9.4. Microbiota and Biogenic Amines 
9.5. Current Lines of Research 

Module 10. Probiotics, Prebiotics, Microbiota, and Health

10.1. Probiotics: Definition, History, Mechanisms of Action 
10.2. Prebiotics: Definition, Types of Prebiotics (Starch, Inulin, FOS Oligosaccharides), Mechanisms of Action 
10.3. Clinical Applications of Probiotics and Prebiotics in Gastroenterology 
10.4. Clinical Applications of Endocrinology and Cardiovascular Disorders 
10.5. Clinical Applications of Probiotics and Prebiotics in Urology 
10.6. Clinical Applications of Probiotics and Prebiotics in Gynecology 
10.7. Clinical Applications of Probiotics and Prebiotics in Immunology: Autoimmunity, Pulmonology, Vaccines 
10.8. Clinical Applications of Probiotics and Prebiotics in Nutritional Diseases. Obesity and Eating Disorders. Metabolism, Malnutrition, and Malabsorption of Nutrients 
10.9. Clinical Applications of Probiotics and Prebiotics in Neurological Diseases. Mental Health. Old Age
10.10. Clinical Applications of Probiotics and Prebiotics in Critically Ill Patients. Cancer 
10.11. Dairy Products as a Natural Source of Probiotics and Prebiotics. Fermented Milk. 
10.12. Safety and Legislation in the Use of Probiotics 

A unique, key, and decisive training experience to boost your professional development”